Insider Trading & Ownership - GSK PLC SPONSORED ADR (GSK)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for GSK PLC SPONSORED ADR
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-09-27
Purchase
2024-10-01
5:54 pm
Wave Life Sciences Ltd.WVEGSK plc
10% Owner
2,791,930$8$22,335,44016,775,691
(Indirect)
View
2023-12-07
Purchase
2024-01-30
4:39 pm
Wave Life Sciences Ltd.WVEGSK plc
10% Owner
3,300,000$5$16,500,00013,983,761
(Indirect)
View
2021-07-02
Purchase
2021-07-06
4:38 pm
CVRx Inc.CVRXGLAXOSMITHKLINE PLC
10% Owner
275,000$18$4,950,0001,007,583
(Indirect)
View
2021-05-20
Sale
2021-05-24
5:04 pm
Innoviva Inc.INVAGLAXOSMITHKLINE PLC
10% Owner
32,005,260$12.25$392,064,4350
(Indirect)
View
2021-02-17
Purchase
2021-02-19
4:50 pm
Decibel Therapeutics Inc.DBTXGLAXOSMITHKLINE PLC
Director
150,000$18$2,700,0001,183,663
(Indirect)
View
2020-07-14
Sale
2020-09-18
12:04 pm
BICYCLE THERAPEUTICS plcBCYCGLAXOSMITHKLINE PLC
10% Owner
4,744$19.36$91,8261,910,531
(Indirect)
View
2020-07-24
Purchase
2020-07-30
8:56 pm
GENOCEA BIOSCIENCES INC.GNCAGLAXOSMITHKLINE PLC
10% Owner
1,260,504$2.25$2,836,1345,886,893
(Indirect)
View
2020-07-21
Purchase
2020-07-22
4:18 pm
Pandion Therapeutics Inc.PANDGLAXOSMITHKLINE PLC
Director
10% Owner
361,111$18$6,499,9982,262,301
(Indirect)
View
2020-07-14
Purchase
2020-07-16
8:13 pm
Nkarta Inc.NKTXGLAXOSMITHKLINE PLC
Director
10% Owner
833,333$18$14,999,9943,161,432
(Indirect)
View
2020-05-21
Purchase
2020-05-26
4:17 pm
Turning Point Therapeutics Inc.TPTXGLAXOSMITHKLINE PLC
Director
83,333$60$4,999,9802,253,660
(Indirect)
View
2020-05-20
Sale
2020-05-21
5:21 pm
Progyny Inc.PGNYGLAXOSMITHKLINE PLC
10% Owner
4,000,000$25.75$103,000,0006,238,244
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing

Ownership
2023-01-30
4:34 pm
N/A
N/A
Wave Life Sciences Ltd.WVEGSK PLC
10% Owner
0$010,683,761
(Indirect)
View

Ownership
2022-11-14
5:05 pm
N/A
N/A
Spero Therapeutics Inc.SPROGSK PLC
10% Owner
0$09,190,606
(Indirect)
View

Ownership
2022-11-04
4:11 pm
N/A
N/A
23andMe Holding Co.MEGSK PLC
10% Owner
0$039,660,487
(Indirect)
View
2022-09-16
Other
2022-09-20
4:16 pm
N/A
N/A
Theravance Biopharma Inc.TBPHGSK PLC
Former 10% Owner
9,644,807$9.759,644,807
(Indirect)
View
2022-09-16
Other
2022-09-20
4:16 pm
N/A
N/A
Theravance Biopharma Inc.TBPHGSK PLC
Former 10% Owner
269,061,000$09,644,807
(Indirect)
View
2021-07-02
Conversion
2021-07-06
4:38 pm
N/A
N/A
CVRx Inc.CVRXGLAXOSMITHKLINE PLC
10% Owner
13,331,791$01,007,583
(Indirect)
View

Ownership
2021-07-06
4:22 pm
N/A
N/A
CVRx Inc.CVRXGLAXOSMITHKLINE PLC
10% Owner
0$0700,772
(Indirect)
View
2021-06-21
Conversion
2021-06-23
6:14 pm
N/A
N/A
Lyell Immunopharma Inc.LYELGLAXOSMITHKLINE PLC
10% Owner
30,253,189$030,253,189
(Indirect)
View

Ownership
2021-06-17
5:56 pm
N/A
N/A
Lyell Immunopharma Inc.LYELGLAXOSMITHKLINE PLC
10% Owner
0$030,253,189
(Indirect)
View
2021-02-17
Conversion
2021-02-19
4:50 pm
N/A
N/A
Decibel Therapeutics Inc.DBTXGLAXOSMITHKLINE PLC
Director
13,016,132$01,183,663
(Indirect)
View

Ownership
2021-02-11
9:04 pm
N/A
N/A
Decibel Therapeutics Inc.DBTXGLAXOSMITHKLINE PLC
Director
10% Owner
0$01,033,663
(Indirect)
View
2020-07-21
Conversion
2020-07-22
4:18 pm
N/A
N/A
Pandion Therapeutics Inc.PANDGLAXOSMITHKLINE PLC
Director
10% Owner
11,510,727$02,262,301
(Indirect)
View
2020-07-17
Option Award
2020-07-22
4:18 pm
N/A
2030-07-16
Pandion Therapeutics Inc.PANDGLAXOSMITHKLINE PLC
Director
10% Owner
13,997$02,262,301
(Indirect)
View

Ownership
2020-07-16
9:52 pm
N/A
N/A
Pandion Therapeutics Inc.PANDGLAXOSMITHKLINE PLC
Director
10% Owner
0$01,887,193
(Indirect)
View
2020-07-14
Conversion
2020-07-16
8:13 pm
N/A
N/A
Nkarta Inc.NKTXGLAXOSMITHKLINE PLC
Director
10% Owner
10,941,813$03,161,432
(Indirect)
View
2020-07-14
Option Award
2020-07-16
8:13 pm
N/A
2030-07-08
Nkarta Inc.NKTXGLAXOSMITHKLINE PLC
Director
10% Owner
10,700$03,161,432
(Indirect)
View

Ownership(A)
2020-07-14
4:48 pm
N/A
N/A
Nkarta Inc.NKTXGLAXOSMITHKLINE PLC
Director
10% Owner
0$079,090
(Indirect)
View

Ownership
2020-07-09
8:58 pm
N/A
N/A
Nkarta Inc.NKTXGLAXOSMITHKLINE PLC
Director
10% Owner
0$02,238,309
(Indirect)
View

Ownership
2020-01-02
4:06 pm
N/A
N/A
Orchard Therapeutics plcORTXGLAXOSMITHKLINE PLC
Director
10% Owner
0$012,455,252
(Indirect)
View
(A) Indicate amendment filing.